257 related articles for article (PubMed ID: 23200208)
1. [Evaluating the effectiveness of a disease management program diabetes in the German Statutory Health Insurance: first results and methodological considerations].
Drabik A; Graf C; Büscher G; Stock S
Z Evid Fortbild Qual Gesundhwes; 2012; 106(9):649-55. PubMed ID: 23200208
[TBL] [Abstract][Full Text] [Related]
2. [Results of a survey of insurance customers participating in a DMP for diabetes mellitus type 2 of BARMER Health Insurance, Neubrandenburg].
Elkeles T; Heinze S; Eifel R
Gesundheitswesen; 2007 Jan; 69(1):18-25. PubMed ID: 17347928
[TBL] [Abstract][Full Text] [Related]
3. ELSID-Diabetes study-evaluation of a large scale implementation of disease management programmes for patients with type 2 diabetes. Rationale, design and conduct--a study protocol [ISRCTN08471887].
Joos S; Rosemann T; Heiderhoff M; Wensing M; Ludt S; Gensichen J; Kaufmann-Kolle P; Szecsenyi J
BMC Public Health; 2005 Oct; 5():99. PubMed ID: 16202151
[TBL] [Abstract][Full Text] [Related]
4. Medical care of type 2 diabetes in German disease management programmes: a population-based evaluation.
Stark RG; Schunk MV; Meisinger C; Rathmann W; Leidl R; Holle R;
Diabetes Metab Res Rev; 2011 May; 27(4):383-91. PubMed ID: 21308948
[TBL] [Abstract][Full Text] [Related]
5. [Diabetes disease management program. What is its purpose?].
Stoschek J
MMW Fortschr Med; 2006 May; 148(19):49, 51. PubMed ID: 16736710
[No Abstract] [Full Text] [Related]
6. Is there a survival benefit within a German primary care-based disease management program?
Miksch A; Laux G; Ose D; Joos S; Campbell S; Riens B; Szecsenyi J
Am J Manag Care; 2010 Jan; 16(1):49-54. PubMed ID: 20148605
[TBL] [Abstract][Full Text] [Related]
7. Patients with type 2 diabetes benefit from primary care-based disease management: a propensity score matched survival time analysis.
Drabik A; Büscher G; Thomas K; Graf C; Müller D; Stock S
Popul Health Manag; 2012 Aug; 15(4):241-7. PubMed ID: 22401149
[TBL] [Abstract][Full Text] [Related]
8. [Nurse counseling of diabetic patients according to the disease management program (DMP): ethical care also means evidence-based care].
Hasseler M
Pflege Z; 2004 Apr; 57(4):244-8. PubMed ID: 15141492
[No Abstract] [Full Text] [Related]
9. [General practitioners' opinion and attitude towards DMPs and the change in practice routines to implement the DMP "diabetes mellitus type 2"].
Miksch A; Trieschmann J; Ose D; Rölz A; Heiderhoff M; Szecsenyi J
Z Evid Fortbild Qual Gesundhwes; 2011; 105(6):427-33. PubMed ID: 21843845
[TBL] [Abstract][Full Text] [Related]
10. [The quality of chronic care in Germany].
Fullerton B; Nolte E; Erler A
Z Evid Fortbild Qual Gesundhwes; 2011; 105(8):554-62. PubMed ID: 22142877
[TBL] [Abstract][Full Text] [Related]
11. [Introduction of disease management programmes in Germany as reflected by differing interests of health insurance companies and the federal association of statutory health insurance physicians].
Erler A
Gesundheitswesen; 2002 Nov; 64(11):572-7. PubMed ID: 12442215
[TBL] [Abstract][Full Text] [Related]
12. [The German diabetes dilemma: DMP: insufficient management of the diabetic patient in general practice?].
MMW Fortschr Med; 2005 Oct; 147(41):10. PubMed ID: 16270503
[No Abstract] [Full Text] [Related]
13. [Family doctor-centred care in Baden-Wuerttemberg: concept and results of a controlled evaluation study].
Gerlach FM; Szecsenyi J
Z Evid Fortbild Qual Gesundhwes; 2013; 107(6):365-71. PubMed ID: 24075677
[TBL] [Abstract][Full Text] [Related]
14. ["DIabetes Versorgungs-Evaluation" (DIVE)--a national quality assurance initiative at physicians providing care for patients with diabetes].
Danne T; Kaltheuner M; Koch A; Ernst S; Rathmann W; Rüssmann HJ; Bramlage P;
Dtsch Med Wochenschr; 2013 May; 138(18):934-9. PubMed ID: 23613371
[TBL] [Abstract][Full Text] [Related]
15. [Chronic care model: an evidence-based approach to caring for people with chronic disease].
Steurer-Stey C; Rosemann T
Praxis (Bern 1994); 2010 May; 99(11):655-9. PubMed ID: 20506090
[TBL] [Abstract][Full Text] [Related]
16. [Will prescribing all types of insulin no longer be allowed?].
Schmidt K
MMW Fortschr Med; 2006 Mar; 148(10):44-6. PubMed ID: 16612950
[No Abstract] [Full Text] [Related]
17. [Disease management programs in Germany: Validity of the medical documentation].
Linder R; Horenkamp-Sonntag D; Engel S; Köppel D; Heilmann T; Verheyen F
Dtsch Med Wochenschr; 2014 Jan; 139(1-2):19-22. PubMed ID: 24062021
[TBL] [Abstract][Full Text] [Related]
18. ['Optimal care for depression': Freiburg model of integrated care for depressive disorders].
Bermejo I; Hölzel LP; Voderholzer U; van Elst LT; Berger M
Z Evid Fortbild Qual Gesundhwes; 2012; 106(9):625-30. PubMed ID: 23200205
[TBL] [Abstract][Full Text] [Related]
19. [Costs of antihyperglycemic drugs and consumables and treatment satisfaction in patients with type 2 diabetes. Results of the health care research study LIVE-DE (long-acting insulin glargine compared with NPH insulin in Germany)].
Hauner H; Kohlmann T; Landgraf W; Holle R; Pirk O; Scholten T
Dtsch Med Wochenschr; 2009 Jun; 134(23):1207-13. PubMed ID: 19472091
[TBL] [Abstract][Full Text] [Related]
20. [Medical care in times of DMPs].
Daikeler R
Clin Res Cardiol; 2006 Jan; 95 Suppl 1():i130-3. PubMed ID: 16598540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
